IBDEI13M ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19385,1,4,0)
 ;;=4^621.0
 ;;^UTILITY(U,$J,358.3,19385,1,5,0)
 ;;=5^Endometrial Polyps
 ;;^UTILITY(U,$J,358.3,19385,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,19386,0)
 ;;=617.9^^105^1231^22
 ;;^UTILITY(U,$J,358.3,19386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19386,1,4,0)
 ;;=4^617.9
 ;;^UTILITY(U,$J,358.3,19386,1,5,0)
 ;;=5^Endometriosis, site unsp
 ;;^UTILITY(U,$J,358.3,19386,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,19387,0)
 ;;=054.71^^105^1231^24
 ;;^UTILITY(U,$J,358.3,19387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19387,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,19387,1,5,0)
 ;;=5^Herpes simplex of vulva
 ;;^UTILITY(U,$J,358.3,19387,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,19388,0)
 ;;=704.1^^105^1231^25
 ;;^UTILITY(U,$J,358.3,19388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19388,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,19388,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,19388,2)
 ;;=Hirsutism^57407
 ;;^UTILITY(U,$J,358.3,19389,0)
 ;;=V07.4^^105^1231^26
 ;;^UTILITY(U,$J,358.3,19389,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19389,1,4,0)
 ;;=4^V07.4
 ;;^UTILITY(U,$J,358.3,19389,1,5,0)
 ;;=5^Hormone replacement therapy
 ;;^UTILITY(U,$J,358.3,19389,2)
 ;;=^295199
 ;;^UTILITY(U,$J,358.3,19390,0)
 ;;=625.6^^105^1231^28
 ;;^UTILITY(U,$J,358.3,19390,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19390,1,4,0)
 ;;=4^625.6
 ;;^UTILITY(U,$J,358.3,19390,1,5,0)
 ;;=5^Incontinence, stress
 ;;^UTILITY(U,$J,358.3,19390,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,19391,0)
 ;;=628.9^^105^1231^29
 ;;^UTILITY(U,$J,358.3,19391,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19391,1,4,0)
 ;;=4^628.9
 ;;^UTILITY(U,$J,358.3,19391,1,5,0)
 ;;=5^Infertility
 ;;^UTILITY(U,$J,358.3,19391,2)
 ;;=Infertility^62820
 ;;^UTILITY(U,$J,358.3,19392,0)
 ;;=626.4^^105^1231^30
 ;;^UTILITY(U,$J,358.3,19392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19392,1,4,0)
 ;;=4^626.4
 ;;^UTILITY(U,$J,358.3,19392,1,5,0)
 ;;=5^Irregular menstruation
 ;;^UTILITY(U,$J,358.3,19392,2)
 ;;=^270567
 ;;^UTILITY(U,$J,358.3,19393,0)
 ;;=626.2^^105^1231^31
 ;;^UTILITY(U,$J,358.3,19393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19393,1,4,0)
 ;;=4^626.2
 ;;^UTILITY(U,$J,358.3,19393,1,5,0)
 ;;=5^Menometrorrhagia
 ;;^UTILITY(U,$J,358.3,19393,2)
 ;;=Menometrorrhagia^75895
 ;;^UTILITY(U,$J,358.3,19394,0)
 ;;=627.2^^105^1231^43
 ;;^UTILITY(U,$J,358.3,19394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19394,1,4,0)
 ;;=4^627.2
 ;;^UTILITY(U,$J,358.3,19394,1,5,0)
 ;;=5^Perimenopause
 ;;^UTILITY(U,$J,358.3,19394,2)
 ;;=Perimenopause^75863
 ;;^UTILITY(U,$J,358.3,19395,0)
 ;;=611.79^^105^1231^33
 ;;^UTILITY(U,$J,358.3,19395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19395,1,4,0)
 ;;=4^611.79
 ;;^UTILITY(U,$J,358.3,19395,1,5,0)
 ;;=5^Nipple Discharge
 ;;^UTILITY(U,$J,358.3,19395,2)
 ;;=Nipple Discharge^270462
 ;;^UTILITY(U,$J,358.3,19396,0)
 ;;=278.00^^105^1231^34
 ;;^UTILITY(U,$J,358.3,19396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19396,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,19396,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,19396,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,19397,0)
 ;;=626.1^^105^1231^35
 ;;^UTILITY(U,$J,358.3,19397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19397,1,4,0)
 ;;=4^626.1
 ;;^UTILITY(U,$J,358.3,19397,1,5,0)
 ;;=5^Oligomenorrhea
 ;;^UTILITY(U,$J,358.3,19397,2)
 ;;=Oligomenorrhea^108125
 ;;^UTILITY(U,$J,358.3,19398,0)
 ;;=733.00^^105^1231^36
 ;;^UTILITY(U,$J,358.3,19398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19398,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,19398,1,5,0)
 ;;=5^Osteoporosis
 ;;^UTILITY(U,$J,358.3,19398,2)
 ;;=Osteoporosis^87159
 ;;
 ;;$END ROU IBDEI13M
